Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-389

NCT04322032 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Reference drug
DRUG: Test drug

Sponsor

Chong Kun Dang Pharmaceutical